Regional Health Properties RHEP
OTC RHEP
$1.02 +0.00 (+0.00%)
As of: Oct 23, 2026 · 10:39 AM EDT

Regional Health Properties (RHEP) EV to EBIT (2017 - 2026)

Updated

Regional Health Properties' (RHEP) EV to EBIT was 1.65 for Q2 2026, down 44.2% from the prior quarter.

Analysis

Regional Health Properties (RHEP) EV to EBIT (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Regional Health Properties' EV to EBIT came in at -1.61; for FY2025, it was 0.35, down 97.6% from FY2024.

  • By year, EV to EBIT came in at 14.59 in FY2024 and 0.48 in FY2021 (-40.8%).
  • Five-year quarterly EV to EBIT spans a low of 0.35 in Q4 2025 and a high of 33.65 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 103.18 Bn 99.19 Bn -
2 Natera 57.81 Bn 53.49 Bn 485.19 Mn
3 Labcorp Holdings 26.94 Bn 24.69 Bn 1.11 Bn
4 Quest Diagnostics 26.85 Bn 24.98 Bn 1.03 Bn
5 Guardant Health 22.51 Bn 18.57 Bn 219.03 Mn
6 Tenet Healthcare 22.37 Bn 11.37 Bn -
7 Fresenius Medical Care AG 13.20 Bn 5.15 Bn 1.52 Bn
8 BrightSpring Health Services 12.39 Bn 10.72 Bn 492.75 Mn
9 Encompass Health 12.26 Bn 11.92 Bn -
10 Regional Health Properties 4.01 Mn -2.83 Mn 18.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.65
Mar 31, 2026 2.95
Dec 31, 2025 0.35
Mar 31, 2025 33.65
Dec 31, 2024 14.59
Mar 31, 2022 19.74
Dec 31, 2021 0.48
Sep 30, 2021 4.08
Jun 30, 2021 9.36
Mar 31, 2021 0.61
Dec 31, 2020 0.81
Sep 30, 2020 -0.65
Jun 30, 2020 -0.44
Mar 31, 2020 -0.33
Dec 31, 2019 -0.37
Sep 30, 2019 -0.15
Jun 30, 2019 0.41
Mar 31, 2019 0.29
Jun 30, 2018 3.21
Mar 31, 2018 1.06
API Access

Regional Health Properties EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RHEP&period=max&api_key=YOUR_API_KEY